Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pende

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
International Immunology|August 18, 2004
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2Massimo Vitale, Simona Carlomagno, Michela Falco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapseJohanna Endt, Fiona E McCann, Catarina R Almeida, et al.
HLA|April 12, 2022
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypesMichela Falco, Raffaella Meazza, Claudia Alicata, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2014
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cellsKorneel Grauwet, Claudia Cantoni, Monica Parodi, et al.
Frontiers in Immunology|May 6, 2014
Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioningElena Sieni, Valentina Cetica, Yvonne Hackmann, et al.
Cancer Research|January 17, 2015
ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptorsLoredana Cifaldi, Paolo Romania, Michela Falco, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
Haematologica|May 22, 2008
Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3Alessandra Santoro, Sonia Cannella, Antonino Trizzino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for stainingMichela Falco, Elisa Romeo, Stefania Marcenaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2017
The Activating Human NK Cell Receptor KIR2DS2 Recognizes a β<sub>2</sub>-Microglobulin-Independent Ligand on Cancer CellsLavanya Thiruchelvam-Kyle, Sigurd E Hoelsbrekken, Per C Saether, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
International Immunology|August 18, 2004
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2Massimo Vitale, Simona Carlomagno, Michela Falco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapseJohanna Endt, Fiona E McCann, Catarina R Almeida, et al.
HLA|April 12, 2022
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypesMichela Falco, Raffaella Meazza, Claudia Alicata, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2014
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cellsKorneel Grauwet, Claudia Cantoni, Monica Parodi, et al.
Frontiers in Immunology|May 6, 2014
Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioningElena Sieni, Valentina Cetica, Yvonne Hackmann, et al.
Cancer Research|January 17, 2015
ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptorsLoredana Cifaldi, Paolo Romania, Michela Falco, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
Haematologica|May 22, 2008
Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3Alessandra Santoro, Sonia Cannella, Antonino Trizzino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for stainingMichela Falco, Elisa Romeo, Stefania Marcenaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2017
The Activating Human NK Cell Receptor KIR2DS2 Recognizes a β<sub>2</sub>-Microglobulin-Independent Ligand on Cancer CellsLavanya Thiruchelvam-Kyle, Sigurd E Hoelsbrekken, Per C Saether, et al.
Pageof 11